Honeysuckle Health is a health services and specialist data science company creating better pathways to better health. We do this by understanding our customers current and future health needs, helping them to prevent and manage disease risk and make better treatment decisions.
Founded in December 2019, Honeysuckle Health is a joint venture between nib Group (nib) and Cigna Corporation (Cigna) a global health services company, though operating independently of both. Read the nib media release.
Combining deep expertise from Cigna with a dynamic local team, we have the capability in healthcare data science and health service delivery. We have the ability to generate insights from data, to understand future healthcare risk, support decision making of individuals and healthcare providers and deliver healthcare interventions to dramatically improve health outcomes at both an individual and population level.
Our Purpose
Is to create better pathways to better health. We do this by understanding individual’s current and future health needs, helping them to prevent and manage disease risk and make better treatment decisions.
Our Vision
To play a leading role in Australian and New Zealand healthcare systems by guiding healthcare activity and investment. Our ability to generate insights from data, to predict future healthcare risk, measure the impact of and more precisely target health interventions, contract with providers to deliver value-based care, support decision making of individuals and healthcare providers and deliver our own health management programs has dramatically improved health outcomes at both an individual and population level.
For more information on Honeysuckle Health, take a look at our frequently asked questions. Click here to view.